These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25110962)

  • 21. Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats.
    Pérez-Echarri N; Pérez-Matute P; Marcos-Gómez B; Martínez JA; Moreno-Aliaga MJ
    Br J Nutr; 2009 Apr; 101(7):1059-67. PubMed ID: 18755047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cord Blood Adiponectin and Visfatin Concentrations in relation to Oxidative Stress Markers in Neonates Exposed and Nonexposed In Utero to Tobacco Smoke.
    Chełchowska M; Ambroszkiewicz J; Gajewska J; Rowicka G; Maciejewski TM; Mazur J
    Oxid Med Cell Longev; 2016; 2016():4569108. PubMed ID: 27525051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of serum vaspin, apelin, and visfatin levels and stroke risk in a Chinese case-control study.
    Yu D; Huang B; Wu B; Xiao J
    Medicine (Baltimore); 2021 Mar; 100(12):e25184. PubMed ID: 33761698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic-hyperhomocysteinemic guinea-pigs: their relation with NO metabolism.
    Kusku-Kiraz Z; Genc S; Bekpinar S; Unlucerci Y; Olgac V; Uysal M; Gurdol F
    Mol Cell Biochem; 2015 Feb; 400(1-2):69-75. PubMed ID: 25380625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.
    Karbek B; Bozkurt NC; Topaloglu O; Aslan MS; Gungunes A; Cakal E; Delibasi T
    Minerva Endocrinol; 2014 Jun; 39(2):99-105. PubMed ID: 24736484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidant/antioxidant status in premenstrual syndrome.
    Duvan CI; Cumaoglu A; Turhan NO; Karasu C; Kafali H
    Arch Gynecol Obstet; 2011 Feb; 283(2):299-304. PubMed ID: 20084389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between visfatin and some clinical and biochemical parametres in peritoneal dialysis patients.
    Soyoral YU; Erkoc R; Begenik H; Aldemir MN; Kucukoglu ME
    J Pak Med Assoc; 2012 Nov; 62(11):1179-83. PubMed ID: 23866406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R; Akbay E; Muslu N; Sezer K; Cayan F
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
    Huang JF; Huang CF; Yu ML; Dai CY; Huang CI; Yeh ML; Hsieh MH; Yang JF; Hsieh MY; Lin ZY; Chen SC; Chuang WL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):530-5. PubMed ID: 21332548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?
    Leal VO; Lobo JC; Stockler-Pinto MB; Farage NE; Calixto A; Geloneze B; Mafra D
    Ren Fail; 2012; 34(5):577-81. PubMed ID: 22417287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
    Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum visfatin is elevated in Chinese women with polycystic ovary syndrome, but might not be a reliable predictor of their glucose intolerance.
    Hong Y; Zhao XM; Huang LL; Li L; Chen XL; Yang DZ
    J Biol Regul Homeost Agents; 2012; 26(2):221-9. PubMed ID: 22824749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
    Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
    Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term.
    Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):984-8. PubMed ID: 24106768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apelin levels in normal pregnancy.
    Kourtis A; Gkiomisi A; Mouzaki M; Makedou K; Anastasilakis AD; Toulis KA; Gerou S; Gavana E; Agorastos T
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):367-71. PubMed ID: 21521329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antioxidant vitamin concentrations and oxidative stress markers associated with symptoms and severity of premenstrual syndrome: a prospective cohort study.
    Frankel RA; Michels KA; Kim K; Kuhr DL; Omosigho UR; Wactawski-Wende J; Levine L; Perkins NJ; Mumford SL
    BMC Womens Health; 2021 Feb; 21(1):49. PubMed ID: 33530988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia.
    Kucur M; Tuten A; Oncul M; Acikgoz AS; Yuksel MA; Imamoglu M; Balci Ekmekci O; Yilmaz N; Madazli R
    Hypertens Pregnancy; 2014 Nov; 33(4):467-75. PubMed ID: 25068525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visfatin: New marker of oxidative stress in preterm newborns.
    Marseglia L; D'Angelo G; Manti M; Aversa S; Fiamingo C; Arrigo T; Barberi I; Mamì C; Gitto E
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):23-9. PubMed ID: 26525831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.